EconPapers    
Economics at your fingertips  
 

Retail price regulation and innovation: Reference pricing in the pharmaceutical industry

David Bardey (), Antoine Bommier and Bruno Jullien ()

Journal of Health Economics, 2010, vol. 29, issue 2, 303-316

Abstract: Our paper is a first attempt to evaluate the long run impact of reference pricing on pharmaceutical innovation, health and expenditures. The model is based on a dynamic game involving three types of agents: pharmaceutical firms, consumers and a regulatory entity. Pharmaceutical firms choose the level of research investment and its innovative content, then negotiate introductory prices for new drugs with the regulator. Reference pricing affects negatively the intensity of research and it also modifies the types of innovations that are brought to the market, deterring small innovations. The model is calibrated with a small data on statins in France. Our results suggest that reference pricing typically generates a decline in health, whereas discounted expenditures may decrease or increase, depending on the degree of deterrence of cost reducing innovations.

Keywords: Innovation; Me-too; Reference; pricing; Pharmaceutical; laboratories (search for similar items in EconPapers)
Date: 2010
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (22) Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167-6296(09)00143-X
Full text for ScienceDirect subscribers only

Related works:
Working Paper: Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry (2009) Downloads
Working Paper: Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry (2009) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:jhecon:v:29:y:2010:i:2:p:303-316

Access Statistics for this article

Journal of Health Economics is currently edited by J. P. Newhouse, A. J. Culyer, R. Frank, K. Claxton and T. McGuire

More articles in Journal of Health Economics from Elsevier
Bibliographic data for series maintained by Dana Niculescu ().

 
Page updated 2019-12-07
Handle: RePEc:eee:jhecon:v:29:y:2010:i:2:p:303-316